#52026M12319Prior Notification of Concentration: Charlesbank / Nordic Capital / Tecomet / Orchid
AI-generated summary for informational purposes only. Not legal advice. See the original source for the authoritative text.
The law outlines the prior notification of a concentration involving Charlesbank and Nordic Capital, who are acquiring joint control over a newly created joint venture combining their subsidiaries, Tecomet and Orchid. This notification is made under the EU Merger Regulation to assess potential impacts on competition within the market. The joint venture will provide contract manufacturing services for orthopedic implants and instruments.
AI-generated summary. May contain errors. Refer to official sources for legal decisions.
Key Changes
- Introduction of joint venture between Tecomet and Orchid
- Submission of notification under EU Merger Regulation
- Invitation for third-party observations on proposed concentration
Obligations
What this law requires
Notify the EU Commission of the proposed concentration between Charlesbank, Nordic Capital, Tecomet, and Orchid pursuant to Article 4 of Council Regulation (EC) No 139/2004
Provide complete notification documentation to the Commission detailing the concentration structure, including the joint venture formation combining Tecomet and Orchid under joint control
Allow the Commission to conduct preliminary examination of the transaction to determine if it falls within the scope of the Merger Regulation
Permit interested third parties to submit observations regarding the proposed concentration to the Commission within 10 days of publication in the Official Journal
Provide accurate information regarding the business activities of Charlesbank, Nordic Capital, Tecomet, and Orchid, including their roles as contract manufacturing organizations for orthopedic implants and instruments